Enveric Biosciences, Inc. — Form D

Enveric Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-03. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
David JohnsonDirectorGreenwood Village, CO
David JohnsonExecutive OfficerGreenwood Village, CO
Sheila W DeWittDirectorCambridge, MA
George W KeglerDirectorCambridge, MA
Kevin M CoveneyExecutive OfficerCambridge, MA
Marcus W SchabackerDirectorCambridge, MA
Frank W PasqualoneDirectorCambridge, MA
Michael D WebbDirectorCambridge, MA
Joseph E TuckerDirectorCambridge, MA
Joseph E TuckerExecutive OfficerCambridge, MA
David LuciDirectorJersey City, NJ
VIRAJ PATELExecutive OfficerSeattle, WA
Dimitrios AngelisDirectorDenver, CO
Brent KeltonExecutive OfficerAustin, TX
Joseph TuckerDirectorNaples, FL
Joseph TuckerExecutive OfficerNaples, FL
Bob DagherExecutive OfficerNaples, FL
Marcus SchabackerDirectorNaples, FL
Douglas LindDirectorNaples, FL
Frank PasqualoneDirectorCambridge, MA
Frank PasqualoneRelated PersonCambridge, MA
Peter FacchiniExecutive OfficerNaples, FL
George KeglerDirectorNaples, FL
Bevin O'NeilDirectorNaples, FL
Kevin CoveneyExecutive OfficerNaples, FL

Other filings by this issuer (9)

FiledFormOfferingSold
2026-05-04D$5.0M$5.0M
2026-02-11D$1.5M$1.5M
2025-12-23D$107K$107K
2023-04-19D/A$12.8M$12.8M
2022-08-05D$8.6M$8.6M
2021-02-24D$8.4M
2021-01-20D$8.2M
2018-08-28D/A$6.6M$6.6M
2018-08-02D$6.0M$6.0M

More